Professor Richard Beasley
|
|
- Anthony Parrish
- 5 years ago
- Views:
Transcription
1 Professor Richard Beasley University of Otago Director Medical Research Institute of New Zealand Wellington 14:00-14:55 WS #111: Towards Precision Medicine in Asthma -Treatable Traits 15:05-16:00 WS #121: Towards Precision Medicine in Asthma -Treatable Traits (Repeated)
2 Treatable Traits in airways disease Richard Beasley
3 Conflicts of Interest Chair, Asthma & Respiratory Foundation (New Zealand) Adult Asthma Guidelines: A Quick Reference Guide Member, Global Initiative for Asthma Assembly Funding/support: AstraZeneca, Cephalon, Genentech, GSK, Novartis, Sanofi
4 The Problem Airways disease is classified by diagnostic labels such as asthma and COPD, including chronic bronchitis and emphysema. Asthma and COPD are probably not single diseases, but syndromes made up of a complex of multiple related disorders that overlap. Current definitions may not reflect actual phenotypes of airways disease.
5 Why is it important? Specific phenotypes inform Underlying mechanisms Risk factors Natural history Monitoring Treatment
6 What is required? Multidimensional assessment of patients with airways disease which identifies clinical characteristics for which specific treatment strategies are based.
7 Treatable traits Specific characteristics of patients including phenotypes of airways disease, overlapping disorders, comorbidities, environmental and lifestyle factors, that potentially contribute to respiratory health, that are potentially amenable to specific treatments.
8 [The Lancet 2006]
9 [Wenzel, Lancet 2006]
10
11 Inhaled steroid responsiveness PC 20 doubling dose Eosinophilic 5.5 Non-eosinophilic 0.5 [Berry et al. Thorax 2007]
12 [NEJM 2009]
13 [Haldar et al. NEJM 2009]
14 [Lancet Respir 2016]
15 [Ortega et al. Lancet Respir 2016]
16
17 Case 45 year old woman with atopic asthma, Step 3 ICS/LABA treatment and repeat courses of oral steroids for exacerbations, anxiety/depression. Step up to moderate or high dose ICS/LABA treatment
18
19 Potential treatable traits Eosinophilic asthma Psychogenic vocal cord dysfunction Allergic bronchopulmonary aspergillosis Chronic rhinosinusitis Occupational asthma Adherence, inhaler technique
20 Challenge To develop a system whereby the treatable traits are assessed and managed in a primary or secondary care setting.
21
22 [ERS Task Force. ERJ 1999]
23
24 [ATS. Am J Respir Crit Care Med 2000]
25
26 [Robinson et al. Eur Respir J 2003]
27 [Lancet 2006]
28 [Holgate & Polosa. Lancet 2006]
29 [Thorax 2011]
30 [Bel et al. Thorax 2011]
31 [Bel et al. Thorax 2011]
32 [Bel et al. Thorax 2011]
33 [Bel et al. Thorax 2011]
34 [Rev Respir Med 2016]
35 Comorbidities and severe asthma Comorbidity Questionnaires Sensitivity (%) Specificity (%) Sinonasal disease (includes rhinosinusitis and allergic rhinitis) Sinonasal Q naire Allergic rhinitis Score for allergic rhinitis Dysfunctional breathing Nijmegen Paradoxical vocal fold movement Pittsburgh vocal cord dysfunction index Obstructive sleep apnoea Berlin Q naire Anxiety/depression Hospital anxiety & depression score Gastroesophageal reflux GR disease Q naire [Wark et al. Exp Rev Respir Med 2016]
36
37
38 A Quick Reference Guide Richard Beasley, Bob Hancox, Matire Harwood Kyle Perrin, Betty Poot, Janine Pilcher, Jim Reid Api Talemaitoga, Darmiga Thayabaran
39 Treatable Traits Overlapping disorders: COPD Bronchiectasis Allergic bronchopulmonary aspergillosis Dysfunctional breathing, e.g. vocal cord dysfunction Comorbidities: Obesity Gastro-oesophageal reflux disease Rhinitis Sinusitis Depression/anxiety [Agusti et al. ERJ 2016]
40 Treatable Traits Environmental: Smoking Occupational exposures Provoking factors e.g. aspirin, other NSAIDs Behavioural: Adherence Inhaler technique [Agusti et al. ERJ 2016]
41
42
43
ASTHMA & RESPIRATORY FOUNDATION NZ ADULT ASTHMA GUIDELINES: A QUICK REFERENCE GUIDE 1
ASTHMA & RESPIRATORY FOUNDATION NZ ADULT ASTHMA GUIDELINES: A QUICK REFERENCE GUIDE 1 1. Richard Beasley, Bob Hancox, Matire Harwood, Kyle Perrin, Betty Poot, Janine Pilcher, Jim Reid, Api Talemaitoga,
More informationWEBINAR. Difficult-to-treat and severe asthma: changing the paradigm
WEBINAR Difficult-to-treat and severe asthma: changing the paradigm A multidisciplinary discussion on new therapies, and how to identify and manage difficult-to-treat and severe asthma DIFFICULT-TO-TREAT
More informationManaging adults with asthma in primary care: the four-stage consultation
Respiratory conditions Managing adults with asthma in primary care: the four-stage consultation Key practice points: A four-stage consultation is recommended as a framework for managing patients with asthma
More informationDr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher
Professor Richard Beasley University of Otago Director Medical Research Institute of New Zealand Wellington Dr Sarah Mooney Physiotherapy Advanced Clinician Counties Manukau Health NZ Respiratory and Sleep
More informationProf Neil Barnes. Respiratory and General Medicine London Chest Hospital and The Royal London Hospital
Prof Neil Barnes Respiratory and General Medicine London Chest Hospital and The Royal London Hospital ASTHMA: WHEN EVERYTHING FAILS WHAT DO YOU DO? South GP CME 2013, Dunedin Saturday 17 th August 2013
More informationNational Asthma Educator Certification Board Detailed Content Outline
I. THE ASTHMA CONDITION 9 20 1 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationAsma e BPCO: le strategie terapeutiche
Asma e BPCO: le strategie terapeutiche Dott. Marco Contoli ctm@unife.it Sezione di Medicina Interna e Cardio-Respiratoria Dipartimento di Scienze Mediche Università di Ferrara COPD Definition Chronic Obstructive
More informationCOPD: From Phenotypes to Endotypes. MeiLan K Han, M.D., M.S. Associate Professor of Medicine University of Michigan, Ann Arbor, MI
COPD: From Phenotypes to Endotypes MeiLan K Han, M.D., M.S. Associate Professor of Medicine University of Michigan, Ann Arbor, MI Presenter Disclosures MeiLan K. Han Consulting Research support Novartis
More informationLINEE GUIDA DELL ASMA: UP TO DATE
LINEE GUIDA DELL ASMA: UP TO DATE Azienda Ospedaliera Pisana Università degli Studi di Pisa Pierluigi Paggiaro GINA International Executive Committee, Chairman GINA ITaly Cardio-Thoracic and Vascular Department,
More informationSomkiat Wongtim Professor of Medicine Division of Respiratory Disease and Critical Care Chulalongkorn University
Somkiat Wongtim Professor of Medicine Division of Respiratory Disease and Critical Care Chulalongkorn University Asthma-related Comorbidities Comorbid conditions of the upper airways Rhinitis and Sinusitis
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationPublic Dissemination
1. THE ASTHMA CONDITION 9 18 3 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationOptimising asthma management in high risk patients
C L I N I C A L AU D I T Optimising asthma management in high risk patients Valid to June 2022 bpac nz better medicine Audit focus This audit helps primary care health professionals identify patients with
More informationBiologic Agents in the treatment of Severe Asthma
Biologic Agents in the treatment of Severe Asthma Daniel L Maxwell, D.O., FACOI, FAASM Clinical Assistant Professor of Medicine Michigan State University College of Osteopathic Medicine College of Human
More informationUpdate on management of respiratory symptoms. Dr Farid Bazari Consultant Respiratory Physician Kingston Hospital NHS FT
Update on management of respiratory symptoms Dr Farid Bazari Consultant Respiratory Physician Kingston Hospital NHS FT Topics The common respiratory symptoms Cough: causes, diagnosis and therapy Update
More informationCOPD Therapeutic Update
COPD Therapeutic Update The first ever NT patient.. Hubertus PA Jersmann MBBS, MD, PhD, FRACP, FThorSoc, AMA(M) Professor, School of Medicine, University of Adelaide Respiratory and Sleep Physician, Royal
More informationMeasure breath nitric oxide for airway inflammation with the NObreath FeNO monitor
Measure breath nitric oxide for airway inflammation with the NObreath FeNO monitor British technology Improving asthma management, one breath at a time. www.bedfont.com w on 01622 851122 or email ask@bedfont.com
More informationDr Stephen Child. General Physician Auckland. 14:20-14:40 Secondary Care Perspective
Dr Stephen Child General Physician Auckland 14:20-14:40 Secondary Care Perspective Wheeze Witchery Stephen Child MD, FRACP, FRCPC General Physician Respiratory Interest Director of Clinical Training Auckland
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationGlobal Initiative for Asthma (GINA) What s new in GINA 2017?
Global Initiative for Asthma (GINA) GINA Global Strategy for Asthma Management and Prevention Asthma-COPD overlap The word syndrome has been removed from the previous term asthma-copd overlap syndrome
More informationChanging Landscapes in COPD New Zealand Respiratory Conference
Changing Landscapes in COPD New Zealand Respiratory Conference Dr Robert Young BMedSc MBChB DPhil (Oxon) FRACP FRCP Associate Professor Consultant Physician Changing Landscapes in COPD: Summary 1. Overview
More informationEmerging Challenges in Primary Care: The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes
Emerging Challenges in Primary Care: 2018 The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes 1 Faculty Diego J. Maselli, MD FCCP Assistant Professor of
More informationPotential risks of ICS use
Potential risks of ICS use Randomised controlled trial Observational study Systematic review Pneumonia Tuberculosis Bone fracture Skin thinning/easy bruising Cataract Diabetes No effect on fracture risk
More informationAnita Gheller-Rigoni, DO, FACAAI Allergist-Immunologist. Exercise-Induced Vocal Cord Dysfunction
Anita Gheller-Rigoni, DO, FACAAI Allergist-Immunologist Exercise-Induced Vocal Cord Dysfunction Objectives 1. Understand the concept of vocal cord dysfunction 2. Recognize the difference between exercised
More informationAsthma and COPD in older people lumping or splitting? Christine Jenkins Concord Hospital Woolcock Institute of Medical Research
Asthma and COPD in older people lumping or splitting? Christine Jenkins Concord Hospital Woolcock Institute of Medical Research Concord Hospital Woolcock Institute of Medical Research Joe has asthma What
More informationChanging Epidemiology: Quick Facts 9/28/2018. During the year New Treatment Options for COPD: Phenotypes, Endotypes or Treatable Traits?
New Treatment Options for COPD: Phenotypes, Endotypes or Treatable Traits? Conflict of Interest Statement 2018 Speakers Bureau Astra Zeneca Boehringer Ingelheim Genentech Sunovion Ron Balkissoon MD DIH
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Afferent nerves, interactions of, in cough, 20 21 Airway, eosinophilic inflammation of, 124 narrowing of, in asthma, 126 protection of, terms
More informationCOPD and Asthma Update. April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute
COPD and Asthma Update April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute What we ll be talking about COPD: diagnosis, management of stable COPD, COPD exacerbations Asthma: diagnosis,
More informationClinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy
Clinical Implications of Asthma Phenotypes Michael Schatz, MD, MS Department of Allergy Definition of Phenotype The observable properties of an organism that are produced by the interaction of the genotype
More informationSevere Asthma(s): Can THEY be prevented or reversed?
Severe Asthma(s): Can THEY be prevented or reversed? Sally Wenzel, MD Professor of Medicine UPMC Chair in Translational Airway Biology Disclosures Sally Wenzel, M.D. Grant/Research Support: Boehringer-Ingelheim,
More informationPhenotypes of asthma; implications for treatment. Medical Grand Rounds Feb 2018 Jim Martin MD DSc
Phenotypes of asthma; implications for treatment Medical Grand Rounds Feb 2018 Jim Martin MD DSc No conflicts to declare Objectives To understand the varied clinical forms of asthma To understand the pathobiologic
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More information5/1/18. Emerging Challenges in Primary Care: The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes
Emerging Challenges in Primary Care: 2018 The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes 1 Faculty Diego J. Maselli, MD FCCP Assistant Professor of
More informationCurrent Asthma Therapy: Little Need to Phenotype. Phenotypes of Severe Asthma. Cellular Phenotypes 12/7/2012
Subbasement Membrane Thickness(µm) 12/7/212 Current Asthma Therapy: Little Need to Phenotype Phenotypes of Severe Asthma Most mild and to some degree moderate asthmatics respond well to currently available
More informationAsthma COPD Overlap (ACO)
Asthma COPD Overlap (ACO) Dr Thomas Brown Consultant Respiratory Physician Thomas.Brown@porthosp.nhs.uk Dr Hitasha Rupani Consultant Respiratory Physician Hitasha.rupani@porthosp.nhs.uk What is Asthma
More informationADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.
ADULT ASTHMA GUIDE SUMMARY This summary provides busy health professionals with key guidance for assessing and treating adult asthma. Its source document Asthma and Respiratory Foundation NZ Adult Asthma
More informationAn Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease
An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease Carmen Vidal Athens, September 11, 2014 Pucci S & Incorvaia C, 2008; 153:1-2 1. The major player in driving the immune
More informationPersonalized medicine in childhood asthma. Dr Mariëlle Pijnenburg, Erasmus MC Sophia, Rotterdam, NL
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.
More informationBiologics in Asthma: Present and Future
Biologics in Asthma: Present and Future Flavia Hoyte, MD Associate Professor of Medicine Fellowship Training Program Director Division of Allergy and Immunology National Jewish Health and University of
More informationFigure 1: COPD Age Adjusted Death Rates Based on the 1940 and 2000 Standard Population,
Figure 1: COPD Age Adjusted Death Rates Based on the 1940 and 00 Standard Population, 1979-00 Age Adjusted Death Rates per 100,000 Persons 50 45 40 35 30 25 15 10 Years 1979 1980 1981 1982 1983 1984 1985
More informationASTHMA. Dr Liz Gamble BRI
ASTHMA Dr Liz Gamble BRI Diagnosis Clinical: wheeze, breathlessness, chest tightness, cough Variable airflow obstruction: peak flow chart, spirometry with reversibility to bronchodilators Airways hyper-responsiveness
More informationBiologic Therapy in the Management of Asthma. Nabeel Farooqui, MD
Biologic Therapy in the Management of Asthma Nabeel Farooqui, MD None Disclosures Objectives Define severe asthma phenotypes and endotypes Describe the role of biologics in asthma management Review pivotal
More informationEmerging Challenges in Primary Care: 2018 The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes
Emerging Challenges in Primary Care: 2018 The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes 1 Faculty Diego J. Maselli, MD FCCP Assistant Professor of
More informationAmerican Thoracic Society (ATS) Perspective
National Surveillance System for Chronic Lung Disease (CLD): American Thoracic Society (ATS) Perspective Gerard J. Criner, M.D. Chronic Obstructive Pulmonary Disease (COPD) l Definition: Group of chronic
More informationWhat s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university
What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university Management stable COPD Relieve symptoms Improve exercise tolerance Improve health status Prevent
More informationManagement of Acute Exacerbations of COPD
MiCMRC Educational Webinar Management of Acute Exacerbations of COPD August 22, 2018 MiCMRC Educational Webinar Management of Acute Exacerbations of COPD Expert Presenter: Catherine A. Meldrum PhD RN MS
More informationCOUGH. Jim Reid University of Otago Medical School Dunedin, New Zealand
COUGH Jim Reid University of Otago Medical School Dunedin, New Zealand COUGH One of five most common presentations in general practice Remember the law of probability Common things occur commonly But
More informationResearch in Real Life
Research in Real Life Study 1: Exploratory study - identifying the benefits of pmdi versus Diskus for delivering fluticasone/salmeterol combination therapy in patients with chronic obstructive pulmonary
More informationAround-COPD Verona (Italy), January Highlights
Introduction Around-COPD Verona (Italy), January 18 2017 Highlights Prof. Dal Negro chairman of the symposium, opened the congress by highlighting the burden of COPD as a chronic invalidating disease affecting
More informationASTHMA RESOURCE PACK Section 3. Chronic Cough Guidelines
ASTHMA RESOURCE PACK Section 3 Chronic Cough Guidelines NHS Fife Guidelines for the Management of Chronic Cough in Adults In this section: 1. Introduction 2. Scope Guidelines for Management of Chronic
More informationAllergen and Environment in Severe Asthma
Allergen and Environment in Severe Asthma Hye-Ryun Kang MD., PhD. Department of Internal Medicine, Seoul National University Hospital Role of Allergen in Asthma Pathogenesis Early response of allergen
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationBiomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus
ORIGINAL RESEARCH LETTER Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus To the Editor: Asthma is managed using step-wise adjustment of corticosteroid therapy to
More informationObjectives. Phil Slocum, D.O. FCCP, FACOI, FCCM, FACP Professor of Medicine. All that wheezes (or has intermittent dyspnea) is not asthma
* Phil Slocum, D.O. FCCP, FACOI, FCCM, FACP Professor of Medicine Objectives All that wheezes (or has intermittent dyspnea) is not asthma Ockham's Razor does not work in evaluating patients with shortness
More informationImproving Outcomes in the Management & Treatment of Asthma. April 21, Spring Managed Care Forum
Improving Outcomes in the Management & Treatment of Asthma April 21, 2016 2016 Spring Managed Care Forum David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health University
More informationAsthma in Day to Day Practice
Asthma in Day to Day Practice VIJAY.K.VANAM Financial relationships: Disclosures Employed at Mercy Medical Center, Mason City. Nonfinancial relationships: I receive no financial gain from any pharmaceutical
More informationCHALLENGES OF REAL LIFE ASTHMA MANAGEMENT. Dr Chris Lewis Respiratory Physician and Director of Prevocational Training Auckland District Health Board
CHALLENGES OF REAL LIFE ASTHMA MANAGEMENT Dr Chris Lewis Respiratory Physician and Director of Prevocational Training Auckland District Health Board CONFLICT OF INTEREST Employee of Auckland District Health
More information11/15/2017. Highgate Private Hospital (Royal Free London NHS Foundation Trust) Causes of chronic cough
A whistle stop of Chronic Cough For 10min consultations.. Dr Dean Creer Consultant Chest Physician (MBChB, FRCP) Highgate Private Hospital (Royal Free London NHS Foundation Trust) E: drcreer.pa@gmail.com(secretary)
More informationSevere asthma Diagnostic criteria and diagnostic problems
Severe Asthma Series Severe asthma Diagnostic criteria and diagnostic problems Eleni G. Tzortzaki 1, Alberto Papi 2, Nikolaos M. Siafakas 1 1 Department of Thoracic Medicine, University Hospital of Heraklion
More informationCurrent Approaches to Asthma & COPD
10/11/18 Current Approaches to Asthma & COPD Lekshmi Santhosh, M.D. Assistant Professor, Pulm/Critical Care & Hosp Med Primary Care Medicine: Principles & Practice 10.11.2018 Revisiting the Dutch Hypothesis:
More informationRising Incidence of Asthma
Controlling Severe Asthma through Advanced Diagnosis and Treatment Strategies James F. Donohue, MD Professor of Medicine Division of Pulmonary and Critical Care Medicine University of North Carolina at
More informationDifficult Asthma Assessment: A systematic approach
Difficult Asthma Assessment: A systematic approach Dr Naghmeh Radhakrishna Respiratory, Sleep & Allergy Physician Allergy, Asthma & Clinical Immunology Service The Alfred Hospital Melbourne, Australia
More informationChoosing an inhaler for COPD made simple. Dr Simon Hart Castle Hill Hospital
Choosing an inhaler for COPD made simple Dr Simon Hart Castle Hill Hospital 1 Declaration of interests I have received speaker fees, sponsorship to attend conferences, and funding for research from companies
More informationFactors Associated with Dysfunctional Breathing in patients with Difficult to Treat Asthma
Accepted Manuscript Factors Associated with Dysfunctional Breathing in patients with Difficult to Treat Asthma Eve Denton, MBBS Hons MPH FRACP, Janet Bondarenko, B Physio, TunnRen Tay, MBBS MRCP, Joy Lee,
More informationBrian Carlin, MD Disclosures 4/6/2014. Speakers bureau Glaxo Smith Kline Boehringer Ingelheim Philips Respironics Forest Breathe Technologies PneumRx
Brian W. Carlin, MD, FCCP, FAARC, MAACVPR Assistant Professor of Medicine Drexel University School of Medicine Sleep Medicine and Lung Health Consultants Pittsburgh, Pennsylvania Kansas Society for Respiratory
More informationWhich asthma patient has allergic airway inflammation?
Which asthma patient has allergic airway inflammation? C o n t r o l l i n g A l l e r g i c A s t h m a Several underlying diseases can present symptoms similar to asthma. Therefore, a correct diagnos
More informationPulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):
Pulmonary Pearls Christopher H. Fanta, MD Pulmonary and Critical Care Division Brigham and Women s Hospital Partners Asthma Center Harvard Medical School Medical Pearls Definition: Medical fact that is
More informationCase-Compare Impact Report
Case-Compare Impact Report October 8, 20 For CME Activity: Developed through an independent educational grant from Genentech: Moderate to Severe Persistent Asthma: A Case-Based Panel Discussion (March
More informationAsthma Therapy 2017 JOSHUA S. JACOBS, M.D.
Asthma Therapy 2017 JOSHUA S. JACOBS, M.D. BACKGROUND-PREVALENCE Asthma is one of the most common chronic diseases worldwide with an estimated 300 million affected individuals Prevalence is increasing
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationEvolution of asthma from childhood. Carlos Nunes Center of Allergy and Immunology of Algarve, PT
Evolution of asthma from childhood Carlos Nunes Center of Allergy and Immunology of Algarve, PT allergy@mail.telepac.pt Questionnaire data Symptoms occurring once or several times at follow-up (wheeze,
More informationAdvancing COPD treatment strategies with evidencebased. 17:15 19:15 Monday 11 September 2017 ERS 2017, Milan, Italy
Advancing COPD treatment strategies with evidencebased approaches 17:15 19:15 Monday 11 September 2017 ERS 2017, Milan, Italy Increasing understanding of COPD and the effect on guideline evolution. GOLD
More informationEmerging Challenges in Primary Care: 2018 The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes
Emerging Challenges in Primary Care: 2018 The Role of Type 2 Inflammation in Severe Asthma: Integrating Biologic Therapy to Optimize Outcomes 1 Faculty Diego J. Maselli, MD FCCP Assistant Professor of
More informationasthma, order-made medicine, phenotypes 2.1 Cluster analysis by Haldar et al.
Received: 8 June 2015 Accepted: 25 February 2016 DOI: 10.1002/jgf2.7 REVIEW ARTICLE Asthma phenotypes Masahiro Hirose MD, PhD Takahiko Horiguchi MD, PhD Department of Respiratory Medicine II, Fujita Health
More informationBETTER DEFINING AIRWAYS DISEASE WITH TECHNEGAS
cyclopharm 17 May 2018 The Manager Company Announcements Office Australian Securities Exchange Limited 20 Bridge Street Sydney NSW 2000 cyclomedica technegas ultralute Cyclopharm Ltd ABN 74 116 931 250
More informationCOPD and Asthma: Similarities and differences Prof. Peter Barnes
and Asthma: Similarities and Differences and Asthma: 1 Imperial College Peter Barnes FRS, FMedSci, National Heart & Lung Institute Imperial College, London, UK p.j.barnes@imperial.ac.uk Royal Brompton
More informationCOPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013
COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013 None Disclosures Definitions Asthma Asthma is a chronic inflammatory
More informationTHE COPD-ASTHMA OVERLAP SYNDROME
THE COPD-ASTHMA OVERLAP SYNDROME NICOLA A. HANANIA, MD, MS, FRCP(C), FCCP, FACP ASSOCIATE PROFESSOR OF MEDICINE DIRECTOR OF ASTHMA & COPD CLINICAL RESEARCH CENTER BAYLOR COLLEGE OF MEDICINE HOUSTON, TX
More informationWF RESPIRATORY SYSTEM. RESPIRATORY MEDICINE
WF RESPIRATORY SYSTEM. RESPIRATORY MEDICINE 1 Societies 11 History 13 Dictionaries. Encyclopaedias. Bibliographies Use for general works only. Classify with specific aspect where possible 15 Classification.
More informationOutcome, classification and management of wheezing in preschool children Paul L.P. Brand
Outcome, classification and management of wheezing in preschool children Paul L.P. Brand Princess Amalia Children s Clinic Isala klinieken, Zwolle the Netherlands p.l.p.brand@isala.nl Valle de la Luna,
More informationGetting Asthma treatment right. Dr David Cremonesini Specialist Pediatrician American Hospital
Getting Asthma treatment right Dr David Cremonesini Specialist Pediatrician American Hospital cdavid@ahdubai.com } Consultant Paediatrician from UK of 5.5 years } Speciality in Allergy / Asthma (PG Certificate)
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationChronic Obstructive Lung Disease
Chronic Obstructive Lung Disease HIGHLIGHTS According to the 23 Canadian Community Health Survey (CCHS), one out of every 1 seniors living in Peel reported that they had asthma, as diagnosed by a health-care
More informationCombination Beta2-Agonist/Corticosteroid Inhalers Policy Number: Last Review: Origination: Next Review: Policy When Policy Topic is covered:
Combina ation Beta2-Agonist/Corticosteroid Inhalers Policy Number: 5.01.572 Origination: 06/2014 Last Review: 07/2014 Next Review: 07/2015 Policy BCBSKC will provide coverage for the combination beta2-agonist/corticosteroid
More informationEndobronchial Thermoplasty
Endobronchial Thermoplasty Asthma Education Day Thursday, October 30, 2014 Cynthia Ray, MD, FCCP Senior Staff Physician Interventional Pulmonology Pulmonary and Critical Care Medicine Henry Ford Hospital
More informationCOPD Bronchiectasis Overlap Syndrome.
COPD Bronchiectasis Overlap Syndrome. John R Hurst 1, J Stuart Elborn 2, and Anthony De Soyza 3 on Behalf of the BRONCH-UK Consortium (D Bilton, J Bradley, JS Brown, J Duckers, F Copeland, A Floto, J Foweraker,
More informationMinimum Competencies for Asthma Care in Schools: School Nurse
Minimum Competencies for Asthma Care in Schools: School Nurse Area I. Pathophysiology 1. Explain using simple language and appropriate educational aids the following concepts: a. Normal lung anatomy and
More informationATHLETES & PRESCRIBING PHYSICIANS PLEASE READ TUE APPLICATION CHECKLIST POST INFECTIOUS COUGH
ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ USADA can grant a Therapeutic Use Exemption (TUE) in compliance with the World Anti- Doping Agency International Standard for TUEs. The TUE application process
More informationBlood eosinophil count: a biomarker of an important treatable trait in patients with airway disease
EDITORIAL COPD Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Ian D. Pavord 1 and Alvar Agusti 2 Affiliations: 1 Respiratory Medicine Unit, Nuffield
More informationSome Facts About Asthma
Some Facts About Asthma Contents What is asthma? Diagnosing asthma Asthma symptoms Asthma triggers Thanks What is asthma?? Asthma is a chronic lung-disease that inflames and narrows the airways (tubes
More informationEpidemiology of COPD Prof. David M. Mannino, M.D.
Epidemiology of COPD David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health College of Public Health University of Kentucky 1 Outline Definitions Severity Progression
More informationExhaled Nitric Oxide Today s Asthma Biomarker. Richard F. Lavi, MD FAAAAI FAAP
Exhaled Nitric Oxide Today s Asthma Biomarker Richard F. Lavi, MD FAAAAI FAAP Objectives Describe exhaled nitric oxide physiology and pathophysiology Review the current literature regarding exhaled nitric
More informationDifferent kinds of asthma, different kinds of therapies
Different kinds of asthma, different kinds of therapies Friday 10 th November 2017 XXXIII Congresso Sezione SIAAIC Toscana Professor Neil Barnes Medical Head Global Respiratory Franchise, GSK Brentford,
More informationSevere Asthma & Exacerbations: Dawn of a New Era?
Severe Asthma & Exacerbations: Dawn of a New Era? Christophe von Garnier Department of Pulmonary Medicine Syndromes, Phenotypes & Endotypes Asthma Syndrome Variable symptoms, expiratory airflow limitation,
More informationClinical profile of patients with adult-onset eosinophilic asthma
ORIGINAL ARTICLE ASTHMA Clinical profile of patients with adult-onset eosinophilic asthma Jantina C. de Groot 1, Huib Storm 2, Marijke Amelink 3, Selma B. de Nijs 3, Edwin Eichhorn 4, Bennie H. Reitsma
More informationDo We Need Biologics in Pediatric Asthma Management?
Do We Need Biologics in Pediatric Asthma Management? Ting Fan LEUNG, MBChB, MD, FRCPCH, FAAAAI Professor and Chairman Department of Paediatrics The Chinese University of Hong Kong Asthma and Allergy by
More informationBrooke L. Gildon, Pharm.D., BCPS, BCPPS, AE C
Brooke L. Gildon, Pharm.D., BCPS, BCPPS, AE C Associate Professor of Pharmacy Practice Southwestern Oklahoma State University College of Pharmacy Oklahoma Society of Health System Pharmacists Annual Meeting
More informationAmanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ
Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ Financial Disclosures Advanced Practiced Advisory Board for Circassia Learning Objectives 1. Briefly
More informationGlobal Initiative for Asthma (GINA) What s new in GINA 2016?
Global Initiative for Asthma (GINA) What s new in GINA 2016? GINA Global Strategy for Asthma Management and Prevention GINA: A Brief History Established in 1993 Collaboration between NHLBI and WHO Multiple
More information